FI110668B - Användning av probiotika för primärprofylax av atopiska sjukdomar - Google Patents
Användning av probiotika för primärprofylax av atopiska sjukdomar Download PDFInfo
- Publication number
- FI110668B FI110668B FI20001460A FI20001460A FI110668B FI 110668 B FI110668 B FI 110668B FI 20001460 A FI20001460 A FI 20001460A FI 20001460 A FI20001460 A FI 20001460A FI 110668 B FI110668 B FI 110668B
- Authority
- FI
- Finland
- Prior art keywords
- atopic
- months
- children
- use according
- probiotic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/853—Lactobacillus
- Y10S435/856—Lactobacillus casei
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Claims (6)
1. Användning av levande probiotiska mjölksyre- eller bifidobakterier, som har liknande probiotiska egenskaper som stammen Lactobacillus casei ssp. rhamnosus (ATCC 53103) 5 eller stammen Bifidobacterium lactis Bb-12, och vilka har som särdrag att befrämja tidig bifidogen tarmkanalmikroflora, för att framställa en sammansättning, som är användbar för primärprofylax av atopiska sjukdomar hos ett smäbarn med hög risk för atopiska sjuk-domar, för att administreras tili en gravid kvinna under ätminstone tva veckor före förlossningen, och efter förlossningen tili det nyfödda smäbarnet under ätminstone tva 10 mänader.
2. Användning enligt patentkravet 1, väri sammansättningen administreras efter förlossningen via den ammande modern.
3. Användning enligt patentkravet 1 eller 2, väri sammansättningen innehäller ca 1 x 108 - ca 1 x 1010 kolonibildande enheter av probiotiska bakterier.
4. Användning enligt nägot av patentkraven 1-3, väri mjölksyrebakterierna är av stammen Lactobacillus casei ssp. rhamnosus (ATCC 53103). ;··* 20
: 5. Användning enligt nägot av patentkraven 1-3, väri bifidobakterierna är av stammen ;:1 Bifidobacterium lactis Bb-12.
6. Användning enligt nägot av patentkraven 1-3, väri de probiotiska bakterierna innefattar 25 en blandning av mjölksyrebakterier och bifidobakterier. • · • · • · » * I · I I ·
Priority Applications (16)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20001460A FI110668B (sv) | 2000-06-20 | 2000-06-20 | Användning av probiotika för primärprofylax av atopiska sjukdomar |
PT91642843T PT2201955T (pt) | 2000-06-20 | 2001-06-20 | Bifidobacterium lactis bb-12 na prevenção primária de doenças atópicas |
EP01951716A EP1296694B1 (en) | 2000-06-20 | 2001-06-20 | Probiotics in primary prevention of atopic diseases |
DE01951716T DE01951716T1 (de) | 2000-06-20 | 2001-06-20 | Probiotika zur primären prävention atopischer erkrankungen |
US10/311,706 US7112322B2 (en) | 2000-06-20 | 2001-06-20 | Probiotics in primary prevention of atopic diseases |
DE60139554T DE60139554D1 (de) | 2000-06-20 | 2001-06-20 | Probiotika zur primären prävention atopischer erkrankungen |
ES01951716T ES2329549T3 (es) | 2000-06-20 | 2001-06-20 | Probioticos para la prevencion primaria de enfermedades atopicas. |
AU72572/01A AU784921B2 (en) | 2000-06-20 | 2001-06-20 | Probiotics in primary prevention of atopic diseases |
EP09164284.3A EP2201955B1 (en) | 2000-06-20 | 2001-06-20 | Bifidobacterium lactis Bb-12 in primary prevention of atopic diseases |
ES09164284T ES2754797T3 (es) | 2000-06-20 | 2001-06-20 | Bifidobacterium lactis Bb-12 en prevención primaria de enfermedades atópicas |
EP09164285.0A EP2206507B1 (en) | 2000-06-20 | 2001-06-20 | Probiotics for use in primary prevention of atopic diseases |
AT01951716T ATE439138T1 (de) | 2000-06-20 | 2001-06-20 | Probiotika zur primären prävention atopischer erkrankungen |
ES09164285T ES2721848T3 (es) | 2000-06-20 | 2001-06-20 | Probióticos para su uso en la prevención primaria de enfermedades atópicas |
PT01951716T PT1296694E (pt) | 2000-06-20 | 2001-06-20 | Probióticos na prevenção primária de doenças atópicas |
PCT/FI2001/000588 WO2001097822A1 (en) | 2000-06-20 | 2001-06-20 | Probiotics in primary prevention of atopic diseases |
US11/225,204 US7988960B2 (en) | 2000-06-20 | 2005-09-14 | Probiotics in primary prevention of atopic diseases |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20001460A FI110668B (sv) | 2000-06-20 | 2000-06-20 | Användning av probiotika för primärprofylax av atopiska sjukdomar |
FI20001460 | 2000-06-20 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI20001460A0 FI20001460A0 (sv) | 2000-06-20 |
FI20001460A FI20001460A (sv) | 2001-12-21 |
FI110668B true FI110668B (sv) | 2003-03-14 |
Family
ID=8558595
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI20001460A FI110668B (sv) | 2000-06-20 | 2000-06-20 | Användning av probiotika för primärprofylax av atopiska sjukdomar |
Country Status (9)
Country | Link |
---|---|
US (2) | US7112322B2 (sv) |
EP (3) | EP2201955B1 (sv) |
AT (1) | ATE439138T1 (sv) |
AU (1) | AU784921B2 (sv) |
DE (2) | DE60139554D1 (sv) |
ES (3) | ES2721848T3 (sv) |
FI (1) | FI110668B (sv) |
PT (2) | PT1296694E (sv) |
WO (1) | WO2001097822A1 (sv) |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1364586A1 (en) * | 2002-05-24 | 2003-11-26 | Nestec S.A. | Probiotics and oral tolerance |
JP4212838B2 (ja) | 2002-06-26 | 2009-01-21 | カルピス株式会社 | 抗アレルギー剤 |
CN100421676C (zh) | 2003-12-17 | 2008-10-01 | 纽迪西亚公司 | 乳酸产生细菌和肺功能 |
US7955834B2 (en) | 2004-06-03 | 2011-06-07 | Biogaia Ab | Method for improved breast milk feeding to reduce the risk of allergy |
US7862808B2 (en) | 2004-07-01 | 2011-01-04 | Mead Johnson Nutrition Company | Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12 |
EP1731137A1 (fr) * | 2005-06-08 | 2006-12-13 | Nestec S.A. | Composition cosmétique ou dermatologique pour peaux sèches et/ou sensibles |
FR2876029B1 (fr) * | 2004-10-04 | 2008-11-14 | Oreal | Composition cosmetique et/ou dermatologique pour peaux sensibles. |
BRPI0516437A (pt) * | 2004-10-04 | 2008-09-02 | Oreal E Nestec S A L | utilização de uma quantidade eficaz de pelo menos um microorganismo, processo de tratamento cosmético, composição cosmética e/ou dermatológica e composição para absorção oral |
EP1642570A1 (fr) | 2004-10-04 | 2006-04-05 | L'oreal | Composition cosmétique et/ou dermatologique pour peaux sensibles |
ITMI20042189A1 (it) | 2004-11-16 | 2005-02-16 | Anidral Srl | Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale |
RU2270248C1 (ru) * | 2004-12-31 | 2006-02-20 | Открытое акционерное общество "Лианозовский молочный комбинат" | Штамм бифидобактерий bifidobacterium lactis 668, используемый для приготовления кисломолочных, ферментированных и неферментированных пищевых продуктов, биологически активных добавок, бактериальных препаратов и косметических средств |
US20060233762A1 (en) * | 2005-04-15 | 2006-10-19 | Mcmahon Robert J | Method for treating or preventing systemic inflammation in formula-fed infants |
US7303745B2 (en) | 2005-04-15 | 2007-12-04 | Bristol-Myers Squibb Company | Method for preventing or treating the development of respiratory allergies |
WO2006119780A2 (en) | 2005-05-11 | 2006-11-16 | Chr. Hansen A/S | New antibiotic-sensitive lactic acid bacteria strains |
JP2009067679A (ja) * | 2005-12-27 | 2009-04-02 | Univ Of Tokushima | 抗ヒスタミン作用を有する医薬 |
EP1993577B1 (en) | 2006-03-10 | 2014-02-12 | N.V. Nutricia | Use of non-digestable sacharides for giving an infant the best start after birth |
US8226936B2 (en) | 2006-11-15 | 2012-07-24 | Chr-Hansen A/S | Tetracycline-sensitive bifidobacteria strains |
JP5689601B2 (ja) | 2006-12-11 | 2015-03-25 | デュポン ニュートリション バイオサイエンシーズ エーピーエス | 組成物 |
US20110020283A1 (en) * | 2007-02-22 | 2011-01-27 | Schrezenmeir Juergen | Probiotic, gram-positive bacteria for the prophylaxis, suppression, or elimination of allergic reactions in humans |
CN101273738B (zh) * | 2007-03-28 | 2011-06-01 | 哈尔滨正方科技有限公司 | 在常温下保持高活菌数的调配型酸性乳饮料的制备方法 |
EP1974743A1 (en) * | 2007-03-28 | 2008-10-01 | Nestec S.A. | Probiotics to Improve Gut Microbiota |
EP1974734A1 (en) † | 2007-03-28 | 2008-10-01 | Nestec S.A. | Probiotics for reduction of risk of obesity |
EP2145310A4 (en) * | 2007-04-30 | 2013-04-24 | Clinical Decision Support Llc | SYSTEM AND METHOD FOR COMPUTERIZED DIAGNOSTIC ARBITRATOR AND MEDICAL ADVICE |
FR2920305B1 (fr) | 2007-09-04 | 2010-07-30 | Oreal | Utilisation d'un lysat de bifidobacterium species pour le traitement de peaux sensibles. |
FR2920304B1 (fr) | 2007-09-04 | 2010-06-25 | Oreal | Utilisation cosmetique de lysat bifidobacterium species pour le traitement de la secheresse. |
CN102014673B (zh) | 2008-03-28 | 2014-07-30 | 雀巢产品技术援助有限公司 | 用于怀孕的雌性哺乳动物的以增强她们的后代的免疫性的益生菌剂 |
US20110053889A1 (en) * | 2008-09-02 | 2011-03-03 | Joanne Szabo | Prenatal and postnatal screening and treatment of critical monosaccharide deficiencies for neurologic and immunologic function |
FR2942719B1 (fr) | 2009-03-04 | 2011-08-19 | Oreal | Utilisation de microorganismes probiotiques pour limiter les irritations cutanees |
JP2013507394A (ja) * | 2009-10-09 | 2013-03-04 | プロセラ インコーポレイテッド | 自閉症スペクトル障害と診断されたヒトにおいて自閉症スペクトル障害に関連する少なくとも一つの症状を低減するための、ペディオコッカス属を含む組成物及び方法 |
CN102269858A (zh) | 2010-06-02 | 2011-12-07 | 北京智朗芯光科技有限公司 | 自动聚焦系统和自动聚焦方法 |
WO2012000963A1 (en) * | 2010-06-30 | 2012-01-05 | Nestec S.A. | Use of caftaric acid and lactic bacterium in food supplement for regulating skin pigmentation |
NZ612504A (en) | 2010-12-31 | 2015-02-27 | Abbott Lab | Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents |
EP2658547A1 (en) | 2010-12-31 | 2013-11-06 | Abbott Laboratories | Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides |
EE05721B1 (et) | 2011-02-25 | 2014-08-15 | OÜ Tervisliku Piima Biotehnoloogiate Arenduskeskus | Isoleeritud mikroorganismi tüvi L. plantarum MCC1 DSM 23881 ja selle kasutamine |
EP2510932A1 (en) | 2011-04-15 | 2012-10-17 | Nestec S.A. | Lactobacillus paracasei NCC2461 (ST11) for use by perinatal maternal administration in the reduction and prevention of allergies in progeny |
TR201809987T4 (tr) | 2011-06-20 | 2018-08-27 | Heinz Co Brands H J Llc | Probiyotik bileşimler ve yöntemler. |
US11446316B2 (en) | 2011-07-22 | 2022-09-20 | Abbott Laboratories | Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract |
BR112014004772A2 (pt) | 2011-08-29 | 2017-03-21 | Abbott Lab | oligossacarídeos do leite humano para evitar danos e/ou promover a cura do trato gastrointestinal |
EP2617296A1 (en) * | 2012-01-19 | 2013-07-24 | Nestec S.A. | A composition comprising specific Lactobacillus helveticus strains and reducing food and/or respiratory allergy symptoms |
CN104780932A (zh) | 2012-02-29 | 2015-07-15 | 伊西康内外科公司 | 微生物区系的组合物及与其相关的方法 |
AU2013277316B2 (en) | 2012-06-18 | 2018-03-01 | H.J. Heinz Company Brands Llc | Gluten-related disorders |
US9925223B2 (en) | 2012-09-25 | 2018-03-27 | Regents Of The University Of Minnesota | Methods for making and using antimicrobial peptides |
BR112015028164B1 (pt) | 2013-05-10 | 2022-02-08 | H.J. Heinz Company Brands Llc | Usos da bactéria probiótica, lactobacillus paracasei, para tratar uma infecção microbiana e para prevenir ou reduzir a gravidade de uma infecção microbiana |
US20150064304A1 (en) * | 2013-09-03 | 2015-03-05 | Mario Medri | Probiotic lozenge, method of making same, and uses thereof |
RU2697650C1 (ru) * | 2013-11-15 | 2019-08-16 | Сосьете Де Продюи Нестле С.А. | Композиции для профилактики или лечения аллергий у младенцев, рожденных или вскармливаемых матерями несекреторного типа, путем обеспечения фукозилированными олигосахаридами, в частности среди младенцев, подверженных риску или рожденных с помощью кесарева сечения |
WO2015090349A1 (en) | 2013-12-16 | 2015-06-25 | Nestec S.A. | Probiotic nutritional intervention during pregnancy and optionally lactation to reduce risk of allergy in infants |
EP2886660A1 (en) * | 2013-12-20 | 2015-06-24 | Rigas Tehniska universitate | A fluorescent in situ hybridization method for identification of a microorganism |
EP3212001A4 (en) | 2014-10-31 | 2018-04-25 | Whole Biome Inc. | Methods and compositions relating to microbial treatment and diagnosis of disorders |
EP3270938A4 (en) * | 2015-03-18 | 2018-12-19 | Whole Biome Inc. | Methods and compositions relating to microbial treatment and diagnosis of skin disorders |
CA2950839C (en) * | 2016-01-30 | 2023-09-12 | Cooper Technologies Company | Equipment rack and components thereof |
CN111372596A (zh) | 2017-08-30 | 2020-07-03 | 潘德勒姆治疗公司 | 用于治疗微生物组相关病症的方法和组合物 |
AU2019410036A1 (en) * | 2018-12-21 | 2021-06-03 | Société des Produits Nestlé S.A. | Probiotic combination for treatment of allergic disorders |
WO2021138599A1 (en) * | 2020-01-03 | 2021-07-08 | Forte Subsidiary, Inc. | Cosmetic compositions |
CN116744950A (zh) * | 2020-11-24 | 2023-09-12 | 强生消费者公司 | 预防、延迟或改善特应性疾病的方法 |
WO2024042229A1 (en) | 2022-08-25 | 2024-02-29 | Chr. Hansen A/S | Bifidobacterium strains with improved stability |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5591446A (en) * | 1989-04-04 | 1997-01-07 | Beiersdorf, A.G. | Methods and agents for the prophylaxis of atopy |
US5246591A (en) * | 1990-07-13 | 1993-09-21 | Pact, Incorporated | Separation of metal ions on an anion exchange resin by chromatographic elution |
BE1009359A7 (fr) * | 1995-05-19 | 1997-02-04 | Univ Bruxelles | Procede de detection et/ou de quantification de ligands specifiques d'une pathologie liee a une reponse allergique. |
FI104465B (sv) * | 1995-06-14 | 2000-02-15 | Valio Oy | Proteinhydrolysat för behandling och förebyggande av allergier samt framställning och användning av dessa |
EP0904784A1 (en) * | 1997-09-22 | 1999-03-31 | N.V. Nutricia | Probiotic nutritional preparation |
GB9808579D0 (en) | 1998-04-22 | 1998-06-24 | Novartis Nutrition Ag | Improvements in or relating to organic compounds |
JP4010062B2 (ja) * | 1998-09-02 | 2007-11-21 | 医療法人社団青藍会 | アトピー性皮膚炎を防ぐ保健食品 |
JP2000086524A (ja) * | 1998-09-05 | 2000-03-28 | Shadan Seirankai | 生きた腸内細菌を含有する抗アレルギー剤 |
AUPQ415899A0 (en) * | 1999-11-19 | 1999-12-16 | Vasse Research Institute Pty Ltd | Compositions for and methods of treatment of allergic diseases |
-
2000
- 2000-06-20 FI FI20001460A patent/FI110668B/sv active
-
2001
- 2001-06-20 DE DE60139554T patent/DE60139554D1/de not_active Expired - Lifetime
- 2001-06-20 AU AU72572/01A patent/AU784921B2/en not_active Expired
- 2001-06-20 EP EP09164284.3A patent/EP2201955B1/en not_active Expired - Lifetime
- 2001-06-20 DE DE01951716T patent/DE01951716T1/de active Pending
- 2001-06-20 WO PCT/FI2001/000588 patent/WO2001097822A1/en active Application Filing
- 2001-06-20 PT PT01951716T patent/PT1296694E/pt unknown
- 2001-06-20 EP EP09164285.0A patent/EP2206507B1/en not_active Expired - Lifetime
- 2001-06-20 ES ES09164285T patent/ES2721848T3/es not_active Expired - Lifetime
- 2001-06-20 PT PT91642843T patent/PT2201955T/pt unknown
- 2001-06-20 ES ES01951716T patent/ES2329549T3/es not_active Expired - Lifetime
- 2001-06-20 US US10/311,706 patent/US7112322B2/en not_active Expired - Lifetime
- 2001-06-20 ES ES09164284T patent/ES2754797T3/es not_active Expired - Lifetime
- 2001-06-20 AT AT01951716T patent/ATE439138T1/de not_active IP Right Cessation
- 2001-06-20 EP EP01951716A patent/EP1296694B1/en not_active Expired - Lifetime
-
2005
- 2005-09-14 US US11/225,204 patent/US7988960B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US7988960B2 (en) | 2011-08-02 |
PT1296694E (pt) | 2009-10-28 |
PT2201955T (pt) | 2019-11-25 |
EP2206507A1 (en) | 2010-07-14 |
EP2201955A1 (en) | 2010-06-30 |
US20030180272A1 (en) | 2003-09-25 |
ES2754797T3 (es) | 2020-04-20 |
AU7257201A (en) | 2002-01-02 |
FI20001460A0 (sv) | 2000-06-20 |
WO2001097822A1 (en) | 2001-12-27 |
EP2201955B1 (en) | 2019-08-14 |
EP1296694B1 (en) | 2009-08-12 |
ATE439138T1 (de) | 2009-08-15 |
US20060013806A1 (en) | 2006-01-19 |
AU784921B2 (en) | 2006-07-27 |
ES2329549T3 (es) | 2009-11-27 |
US7112322B2 (en) | 2006-09-26 |
EP2206507B1 (en) | 2019-03-13 |
ES2721848T3 (es) | 2019-08-05 |
EP1296694A1 (en) | 2003-04-02 |
DE01951716T1 (de) | 2005-06-23 |
DE60139554D1 (de) | 2009-09-24 |
FI20001460A (sv) | 2001-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI110668B (sv) | Användning av probiotika för primärprofylax av atopiska sjukdomar | |
Dzidic et al. | Oral microbiota maturation during the first 7 years of life in relation to allergy development | |
JP5117171B2 (ja) | 抗アレルギーの乳酸菌 | |
Pedrosa et al. | Survival of yogurt-containing organisms and Lactobacillus gasseri (ADH) and their effect on bacterial enzyme activity in the gastrointestinal tract of healthy and hypochlorhydric elderly subjects | |
Kalliomäki et al. | Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing | |
Shadid et al. | Effects of galactooligosaccharide and long-chain fructooligosaccharide supplementation during pregnancy on maternal and neonatal microbiota and immunity—a randomized, double-blind, placebo-controlled study | |
Duffy et al. | Modulation of rotavirus enteritis during breast-feeding: implications on alterations in the intestinal bacterial flora | |
US9707258B2 (en) | Bioconversion of milk with Bifidobacterium breve for treatment of allergic manifestions in infants | |
BG107299A (bg) | Употреба на lactobacillus casei в имуностимулиращи пептиди | |
JP6985342B2 (ja) | ビフィドバクテリウム ラクティス gkk2、それを含む組成物、およびアレルギー性喘息改善のためのその使用 | |
JP2020523329A (ja) | バチルス・コアグランスの脂質低下効果 | |
JP2023037613A (ja) | 乳酸菌含有組成物 | |
US11723936B2 (en) | Therapeutic uses of Lactobacillus plantarum | |
Yamashita et al. | Intake safety of Lactobacillus helveticus SBT2171 and its effects on nasal and ocular symptoms associated with mites and house dust: An open-label study and a randomized, double-blind, placebo-controlled, parallel group study | |
CN111617061A (zh) | 一种亚精胺在制备提高毛螺菌属细菌丰度制剂中的应用 | |
Mosaddek | Effect of probiotics in the treatment of acute watery diarrhoea in children admitted to a tertiary care hospital in Bangladesh: a non-randomized prospective clinical trial | |
WO2021059241A1 (en) | Microbiome compositions and methods of treatment of atopic diseases | |
CN114990004B (zh) | 一种分泌型免疫球蛋白a包裹态罗伊氏乳杆菌及防治妊娠糖尿病的应用 | |
Chundakkattumalayil et al. | Health endorsing potential of Lactobacillus plantarum MBTU-HK1 and MBTU-HT of Honey bee gut origin | |
McDade et al. | Fetal Programming of Immune Function | |
Mandal | Study of Lactobacillus Isolates from Human Sources with regard to Their Beneficial Physiological Attributes | |
Mosaddek et al. | Effect of Probiotics in Acute Watery Diarrhea in Children Admitted To a Bangladeshi Tertiary-Care Hospital: A Non-Randomized Prospective Clinical Trial | |
Elebeedy et al. | The Healing Effect of Probiotics on Indomethacin Induced Gastric Ulcer in Rats | |
Shabaan et al. | Study of Different Types of Gut Flora among Obese Egyptian Children | |
Cheng et al. | Dietary Probiotic for Allergic Rhinitis: A Systematic |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RF | Appeal filed | ||
PC | Transfer of assignment of patent |
Owner name: NESTEC S.A. Free format text: NESTEC S.A. |
|
FCK | Appeal rejected |